Evercore ISI analyst Michael DiFiore initiated coverage of Skye Bioscience (SKYE) with an Outperform rating and $10 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKYE:
- Skye Bioscience Earnings Call: Positive Outlook Amid Challenges
- Skye Bioscience Releases Q2 2025 Financial Results
- Skye Bioscience debuts ‘Anatomy of Progress’ nimacimab development update series
- Skye Bioscience participates in panel at Evercore obesity event
- Analysts Predict Up to ~590% Spike for These 2 ‘Strong Buy’ Penny Stocks